Pharmaceutical

Sanofi and AstraZeneca to supply additional RSV doses to US

The US government is set to receive an additional 230,000 doses of RSV injection Beyfortus from Sanofi and AstraZeneca in January 2024.

Dec 16, 2023 - 18:00
Sanofi and AstraZeneca to supply additional RSV doses to US
The US government is set to receive an additional 230,000 doses of RSV injection Beyfortus from Sanofi and AstraZeneca in January 2024.
Read the original article

Tags:

Previous Article

Biovac receives IFC loan for vaccine manufacturing in Africa

Next Article

Reneo cuts 70% of staff following Phase III trial failure

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BioCryst Pharmaceuticals gets grant for inhibitors of t...

May 3, 2024

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

Jul 13, 2023

Top health officials call for more research to support fentanyl test strips

Top health officials call for more research to support ...

Jun 10, 2023